Tarmfloran och IBS: En nyckel till att förstå och behandla din mag-tarmsjukdom
Om du lider av Irritable Bowel Syndrome (IBS) har du säkert hört talas om tarmfloran. Men vad är egentligen sambandet mellan dessa mikroskopiska invånare i din tarm och dina IBS-symtom? Låt oss dyka in i denna fascinerande värld och utforska hur din tarmflora kan vara nyckeln till att förstå och hantera din IBS.
Artikelns källor
➔-
- Pittayanon, R., et al. (2019). Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review. Gastroenterology, 157(1), 97-108. https://www.gastrojournal.org/article/S0016-5085(19)34649-9/fulltext
- Tap, J., et al. (2017). Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Gastroenterology, 152(1), 111-123.e8. https://www.gastrojournal.org/article/S0016-5085(16)35174-5/fulltext
- Staudacher, H. M., & Whelan, K. (2016). Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. Proceedings of the Nutrition Society, 75(3), 306-318. https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/altered-gastrointestinal-microbiota-in-irritable-bowel-syndrome-and-its-modification-by-diet-probiotics-prebiotics-and-the-low-fodmap-diet/8A7E00D44BD17B2F192D8EEBE464AD03
- Ford, A. C., et al. (2018). Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. The American Journal of Gastroenterology, 113(9), 1290-1300. [https://journals.lww.com/ajg/Abstract/2018/09000/Efficacy_of_Prebiotics,_Probiotics,_and_Synbiotics.11.aspx]
- Johnsen, P. H., et al. (2018). Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. The Lancet Gastroenterology & Hepatology, 3(1), 17-24. [https://www.thelancet.com/journals/langas/article/PIIS2468-1253(17)30338-2/fulltext]
